Epidemiology of Diverticulitis in Lung Transplant Recipients
Overview
The purpose of this study is to assess incidence, treatment modalities and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) in order to establish improved treatment strategies in this high risk patient collective.
Full Title of Study: “Long-term Follow-up of Lung Transplant Recipients With Diverticulitis”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: December 2013
Detailed Description
Sigmoid diverticulitis is common and potentially problematic in immunosuppressed patients. The choice between conservative and surgical treatment for uncomplicated diverticulitis remains unclear, as well as the value of the Hartmann's procedure (HP) for complicated diverticulitis. Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing our prospective database of around 400 lung transplant recipients transplanted between 1992 and 2013.
Arms, Groups and Cohorts
- Lung transplant recipients with uncomplicated diverticulitis
- Retrospective data analysis of treatment, outcome and recurrency-rate
- Lung transplant recipients with complicated diverticulitis
- Retrospective data analysis of treatment, outcome and recurrency-rate
Clinical Trial Outcome Measures
Primary Measures
- Epidemiology of Diverticulitis in Lung Transplant Recipients
- Time Frame: January 1992- December 2013 (22 years)
- Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing a prospective database of around 400 LTRs transplanted between 1992 and 2013.
Participating in This Clinical Trial
Inclusion Criteria
- Lung transplant recipient – Diverticulitis Exclusion Criteria:
- none
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- University of Zurich
- Provider of Information About this Clinical Study
- Principal Investigator: Nocito Antonio, PD Dr.med. – University of Zurich
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.